Efeitos do Neurofeedback em Transtornos Neurocognitivos e Psiquiátricos em Adultos Tratados Cirurgicamente por Tumor Cerebral
Resumo
Objetivo: Avaliar a eficácia do neurofeedback na melhora de distúrbios neurocognitivos e psiquiátricos em adultos tratados cirurgicamente de tumor cerebral. Métodos: Estudo duplo-cego, randomizado, controlado por placebo para investigar melhora do funcionamento neurocognitivo e psiquiátrico com neurofeedback em adultos que receberam tratamento cirúrgico para um tumor cerebral. Trinta e sete sobreviventes de tumor cerebral e que foram submetidos a neurocirurgia com queixas de déficits neurocognitivos, sintomas depressivos e piora da qualidade de vida foram selecionados. Resultados: Indivíduos tratados cirurgicamente por tumor cerebral apresentaram melhora em suas capacidades de memória e atenção após realizar o tratamento com neurofeedback. O grupo submetido ao tratamento com neurofeedback mostrou aumento significativo. Habilidades cognitivas sofreram melhora depois do tratamento com neurofeedback. Obteve-se aumento dos índices que aferem a qualidade de vida. Os participantes do estudo apresentaram diminuição dos sintomas depressivos após realizar tratamento com neurofeedback. Conclusão: O presente estudo comprovou que o neurofeedback é eficaz no tratamento de déficits de cognição, sintomas depressivos e alterações na qualidade de vida secundários a tumores cerebrais. Estudos futuros com monitorização eletrofisiológica cerebral e ressonância nuclear magnética funcional se fazem necessários para estabelecer e registrar possíveis alterações da fisiologia cerebral propiciadas pelo treino com neurofeedback.
Downloads
Referências
Christiansen H, Reh V, Schmidt MH, Rief W. Slow cortical potential neurofeedback and self-management training in outpatient care for children with ADHD: study protocol and first preliminary results of a randomized controlled trial. Front Hum Neurosci. 2014;8:943.
de Ruiter MA, Schouten-Van Meeteren AY, van Mourik R, Janssen TW, Greidanus JE, Oosterlaan J, et al. Neurofeedback to improve neurocognitive functioning of children treated for a brain tumor: design of a randomized controlled double-blind trial. BMC Cancer. 2012;12:581.
de Ruiter MA, van Mourik R, Schouten-van Meeteren AY, Grootenhuis MA, Oosterlaan J. Neurocognitive consequences of a paediatric brain tumour and its treatment: a meta-analysis. Dev Med Child Neurol. 2013;55(5):408-17.
Fosi T, Lax-Pericall MT, Scott RC, Neville BG, Aylett SE. Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefit. Epilepsia. 2013;54(12):2071-81.
Gevensleben H, Holl B, Albrecht B, Schlamp D, Kratz O, Studer P, et al. Neurofeedback training in children with ADHD: 6-month follow-up of a randomised controlled trial. Eur Child Adolesc Psychiatry. 2010;19(9):715-24.
Hodgson K, Hutchinson AD, Denson L. Nonpharmacological treatments for ADHD: a meta-analytic review. J Atten Disord. 2014;18(4):275-82.
Holtmann M, Sonuga-Barke E, Cortese S, Brandeis D. Neurofeedback for ADHD: a review of current evidence. Child Adolesc Psychiatr Clin N Am. 2014;23(4):789-806.
International Cognition and Cancer Task Force. Nature of the cognitive difficulties. [cited 20 jun 2016]. Available from: http://www.icctf.com/index.php
Lower E, Fleishman S, Cooper A, Zeldis J, Faleck H, Manning D. A phase III, randomized placebo-controlled trial of the safety and efficacy of d-MPH as new treatment of fatigue and “chemobrain” in adult cancer patients. J Clin Oncol. 2005;23(Suppl 16):S729.
May G, Benson R, Balon R, Boutros N. Neurofeedback and traumatic brain injury: a literature review. Ann Clin Psychiatry. 2013;25(4):289-96.
Meyers CA, Perry JR. Introduction. In: Meyers CA, Perry JR, editors. Cognition and cancer. New York (NY): Cambridge University Press; 2008. p. 3-5.
Micoulaud-Franchi JA, Geoffroy PA, Fond G, Lopez R, Bioulac S, Philip P. EEG neurofeedback treatments in children with ADHD: an updated meta-analysis of randomized controlled trials. Front Hum Neurosci. 2014;8:906.
Mulhern RK, White HA, Glass JO, Kun LE, Leigh L, Thompson SJ, et al. Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood. J Int Neuropsychol Soc. 2004;10(2):180-9.
Munivenkatappa A, Rajeswaran J, Indira Devi B, Bennet N, Upadhyay N. EEG Neurofeedback therapy: can it attenuate brain changes in TBI? NeuroRehabilitation. 2014;35(3):481-4.
Simonoff E, Taylor E, Baird G, Bernard S, Chadwick O, Liang H, et al. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability. J Child Psychol Psychiatry. 2013;54(5):527-35.
Sterman MB, Egner T. Foundation and practice of neurofeedback for the treatment of epilepsy. Appl Psychophysiol Biofeedback. 2006;31(1):21-35.
Sterman MB. Basic concepts and clinical findings in the treatment of seizure disorders with EEG operant conditioning. Clin Electroencephalogr. 2000;31(1):45-55.
Surmeli T, Ertem A, Eralp E, Kos IH. Schizophrenia and the efficacy of qEEG-guided neurofeedback treatment: a clinical case series. Clin EEG Neurosci. 2012;43(2):133-44.
Thompson SJ, Leigh L, Christensen R, Xiong X, Kun LE, Heideman RL, et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood
cancer. J Clin Oncol. 2001;19(6):1802-8.
Thornton KE, Carmody DP. Electroencephalogram biofeedback for reading disability and traumatic brain injury. Child Adolesc Psychiatr Clin N Am. 2005;14(1):137-62.
Working in Epidemiology. Muestreo: estimar diferencias entre proporciones. Zaragoza: Universidad de Zaragoza; 2006. Acessado em 10 jun 2016. Disponível em: http://www.winepi.net/sp/index.htm
